Last reviewed · How we verify
NCT06176443
Impact of an Increased Restrictive Factor of One Anastomosis Gastric Bypass on Metabolic Outcomes Type 2 Diabetes.
NA trial testing One anastomosis gastric bypass with combined fundoplication in Obesity, Morbid in 300 participants. Completed in 1 May 2024.
13 January 2024
Quick facts
| Lead sponsor | The Society of Bariatric and Metabolic Surgeons of Kazakhstan |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 300 |
| Start date | 13 January 2020 |
| Primary completion | 13 January 2024 |
| Estimated completion | 1 May 2024 |
| Sites | 1 location across Kazakhstan |
Drugs / interventions tested
- One anastomosis gastric bypass with combined fundoplication
- One anastomosis gastric bypass without combined fundoplication
Conditions studied
- Obesity, Morbid — all drugs for Obesity, Morbid →
- Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →
Sponsor
The Society of Bariatric and Metabolic Surgeons of Kazakhstan
Who can join
Adults 18 to 60, any sex, with Obesity, Morbid or Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to evaluate the effect of an increased restrictive factor of one gastric anastomosis (OAGB) using a "FundoRing" fundoplication on metabolic outcomes in type 2 diabetes mellitus. The randomized controlled trial compared two interventional procedures: one group - using the original fundoplication procedure to enhance the restrictive effect and another group without fundoplication in the standard version of the OAGB.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06176443
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity, Morbid
Currently open trials in the same condition.
- NCT07119437 — Low Impact Laparoscopy In Bariatric Surgery · NA · recruiting
- NCT05927519 — Comparison of Airtraq in Class 2-3 Obese and Nonobese Men During Intubation: a Prospective Randomized Clinical Study · NA · recruiting
- NCT06530212 — Sleeve Gastrectomy With Jejuno-ileal Bypass Versus Single Anastomosis Sleeve Jejunal Bypass · NA · recruiting
- NCT06477120 — Time-restricted Eating Among Pregnant Females With Severe Obesity · NA · recruiting
- NCT06119516 — Transpulmonary Pressure - Guided Mechanical Ventilation in Morbidly Obese ARDS Patients: a Feasibility Study. · NA · recruiting
Other The Society of Bariatric and Metabolic Surgeons of Kazakhstan trials
Trials by the same sponsor.
- NCT07495020 — The Laparoscopic Transit Bipartition With Use Metalic Anastomosis Clip · NA · not yet recruiting
- NCT07189416 — The Same-Day and One Day Gastric Bypass by Use the "FundoRing" Method (Same-Day_FundoRing Trial) · NA · completed
- NCT07486765 — FundoRing Roux-en-Y Gastric Bypass Versus FundoRing One Anastomosis Gastric Bypass · NA · completed
- NCT06338969 — The Impact of Different Carbohydrate Restriction After a Gastric Bypass on the Ketosis and Ketoacidosis · NA · recruiting
- NCT04834635 — The FundoRingOAGB Versus Non-wrapping (Non-banded) Standard Method of Laparoscopic One Anastomosis Gastric Bypass · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06176443 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Society of Bariatric and Metabolic Surgeons of Kazakhstan
- Last refreshed: 21 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06176443.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing